piracetam has been researched along with DDPAC in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The neuropsychiatric symptoms of frontotemporal dementia (FTD) have a profound negative impact on disease outcomes and care burden." | 3.01 | Treatment Efficacy of Pharmacotherapies for Frontotemporal Dementia: A Network Meta-Analysis of Randomized Controlled Trials. ( Carvalho, AF; Chen, TY; Chen, YW; Hsu, CW; Huang, MH; Liang, CS; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC; Zeng, BS, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, MH | 1 |
| Zeng, BS | 1 |
| Tseng, PT | 1 |
| Hsu, CW | 1 |
| Wu, YC | 1 |
| Tu, YK | 1 |
| Stubbs, B | 1 |
| Carvalho, AF | 1 |
| Liang, CS | 1 |
| Chen, TY | 1 |
| Chen, YW | 1 |
| Su, KP | 1 |
1 review available for piracetam and DDPAC
| Article | Year |
|---|---|
Treatment Efficacy of Pharmacotherapies for Frontotemporal Dementia: A Network Meta-Analysis of Randomized Controlled Trials.
Topics: Frontotemporal Dementia; Humans; Network Meta-Analysis; Oxytocin; Piracetam; Randomized Controlled T | 2023 |